INTERCEPT PHARMACEUTICALS, INC. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 38,703 | |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,917 | 51,137 | 42,703 | |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 463.91 | 1,000 | 463,910 | 13,124 | 14.1 K to 13.1 K (-7.08 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 444.25 | 1,000 | 444,246 | 14,124 | 15.1 K to 14.1 K (-6.61 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 432.30 | 1,000 | 432,303 | 15,124 | 16.1 K to 15.1 K (-6.20 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 422.05 | 258 | 108,888 | 16,124 | 16.4 K to 16.1 K (-1.57 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 421.46 | 742 | 312,724 | 16,382 | 17.1 K to 16.4 K (-4.33 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 410.92 | 456 | 187,379 | 17,124 | 17.6 K to 17.1 K (-2.59 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 17,580 | 13.6 K to 17.6 K (+29.46 %) |
| Mar 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,917 | 51,137 | 13,580 | 8.7 K to 13.6 K (+56.76 %) |
| Mar 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 10.40 | 2,000 | 20,800 | 4,000 | |
| Mar 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 421.31 | 2,000 | 842,620 | 6,392 | 8.4 K to 6.4 K (-23.83 %) |
| Mar 11 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 10.40 | 2,000 | 20,800 | 8,392 | 6.4 K to 8.4 K (+31.29 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Option Exercise | M | 37.69 | 20,000 | 753,800 | 110,000 | |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 442.49 | 300 | 132,747 | 0 | 300 to 0 (-100.00 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 441.60 | 1,288 | 568,774 | 300 | 1.6 K to 300 (-81.11 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 440.63 | 812 | 357,791 | 1,588 | 2.4 K to 1.6 K (-33.83 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 439.94 | 502 | 220,849 | 2,400 | 2.9 K to 2.4 K (-17.30 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 438.45 | 898 | 393,732 | 2,902 | 3.8 K to 2.9 K (-23.63 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 436.77 | 1,960 | 856,077 | 3,800 | 5.8 K to 3.8 K (-34.03 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 435.70 | 1,140 | 496,701 | 5,760 | 6.9 K to 5.8 K (-16.52 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 434.57 | 1,949 | 846,975 | 6,900 | 8.8 K to 6.9 K (-22.03 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 433.47 | 7,027 | 3,046,012 | 8,849 | 15.9 K to 8.8 K (-44.26 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 432.84 | 1,724 | 746,218 | 15,876 | 17.6 K to 15.9 K (-9.80 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 431.34 | 339 | 146,223 | 17,600 | 17.9 K to 17.6 K (-1.89 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 429.96 | 361 | 155,214 | 17,939 | 18.3 K to 17.9 K (-1.97 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 428.51 | 700 | 299,956 | 18,300 | 19 K to 18.3 K (-3.68 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 427.05 | 500 | 213,524 | 19,000 | 19.5 K to 19 K (-2.56 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 426.06 | 500 | 213,028 | 19,500 | 20 K to 19.5 K (-2.50 %) |
| Mar 07 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Buy | M | 37.69 | 20,000 | 753,800 | 20,000 | 0 to 20 K |